Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1986 1
1993 1
1996 2
1997 2
1999 1
2000 2
2001 4
2002 3
2003 6
2004 1
2005 3
2006 1
2007 5
2008 2
2009 2
2010 5
2011 4
2012 1
2013 4
2014 5
2015 6
2016 5
2017 8
2018 6
2019 5
2020 3
2021 6
2022 17
2023 14
2024 17
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Calcium-permeable AMPA receptors govern PV neuron feature selectivity.
Hong I, Kim J, Hainmueller T, Kim DW, Keijser J, Johnson RC, Park SH, Limjunyawong N, Yang Z, Cheon D, Hwang T, Agarwal A, Cholvin T, Krienen FM, McCarroll SA, Dong X, Leopold DA, Blackshaw S, Sprekeler H, Bergles DE, Bartos M, Brown SP, Huganir RL. Hong I, et al. Among authors: keijser j. Nature. 2024 Nov;635(8038):398-405. doi: 10.1038/s41586-024-08027-2. Epub 2024 Oct 2. Nature. 2024. PMID: 39358515 Free PMC article.
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment.
Keijser JBD, Stalman EW, Wieske L, Steenhuis M, van Dam KPJ, Kummer LYL, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, Blanco LF, Verstegen NJM, Keijzer S, van Mierlo G, Cristianawati O, Boogaard AJ, van der Straten K, van Rijswijk J, van Gils MJ, Ten Brinke A, van Ham SM, Kuijpers TW, Eftimov F, Rispens T; T2B! Immunity against SARS-CoV-2 study group. Keijser JBD, et al. EBioMedicine. 2025 Mar;113:105620. doi: 10.1016/j.ebiom.2025.105620. Epub 2025 Feb 25. EBioMedicine. 2025. PMID: 40010153 Free PMC article.
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
van Buchem-Post NF, Ouwerkerk W, Stalman EW, van Dam KPJ, Wieske L, Bekkenk MW, Wolkerstorfer A, Spuls P, Musters AH, Bosma AL, Hijnen DJ, Eftimov F, Luiten RM; T2B! immunity against SARS‐CoV‐2 study group; van Kempen ZLE, Stalman EW, Steenhuis M, Kummer LYL, van Dam KPJ, Ten Brinke A, van Ham SM, Kuijpers T, Rispens T, Eftimov F, Wieske L, Killestein J, Kooi AJV, Raaphorst J, Zwinderman AHK, Löwenberg M, Volkers AG, D'Haens GRAM, Takkenberg RB, Tas SW, Hilhorst ML, Vegting Y, Bemelman FJ, Verstegen NJM, Fernandez L, Keijzer S, Keijser JBD, Cristianawati O, Voskuyl AE, Broens B, Sanchez AP, Nejentsev S, Mirfazeli ES, Wolbink GJ, Boekel L, Rutgers BA, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart R, Teng Y, Busch MH, Brusse E, van Doorn PA, Baars M, Schreurs C, van der Pol WL, Goedee HS, van Els CACM, de Wit J. van Buchem-Post NF, et al. Among authors: keijser jbd. J Dermatol. 2025 Apr;52(4):624-633. doi: 10.1111/1346-8138.17664. Epub 2025 Feb 14. J Dermatol. 2025. PMID: 39950702 Free PMC article.
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
Keijzer S, Oskam N, Ooijevaar-de Heer P, Steenhuis M, Keijser JBD, Wieske L, van Dam KPJ, Stalman EW, Kummer LYL, Boekel L, Kuijpers TW, Ten Brinke A, van Ham SM, Eftimov F, Tas SW, Wolbink GJ, Rispens T. Keijzer S, et al. Among authors: keijser jbd. Front Immunol. 2024 Feb 29;15:1314507. doi: 10.3389/fimmu.2024.1314507. eCollection 2024. Front Immunol. 2024. PMID: 38487524 Free PMC article. Review.
Dimerization as a key feature of autoreactive IgA antibody responses.
van Mourik AG, Keijser JBD, van Delft MAM, Reijm S, Bacon A, Rispens T, Levarht NEW, Tjokrodirijo RTN, van Veelen PA, Trouw LA, Toes REM, van Schie KA, Oskam N, van der Woude D; T2B! immunity against SARS-CoV-2 study group. van Mourik AG, et al. Among authors: keijser jbd. Ann Rheum Dis. 2025 Nov 28:S0003-4967(25)04528-5. doi: 10.1016/j.ard.2025.11.003. Online ahead of print. Ann Rheum Dis. 2025. PMID: 41318346 Free article.
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis.
van Kempen ZLE, Stalman EW, Steenhuis M, Kummer LYL, van Dam KPJ, Wilbrink MF, Ten Brinke A, van Ham SM, Kuijpers T, Rispens T, Eftimov F, Wieske L, Killestein J; T2B! immunity against SARS-CoV-2 study group. van Kempen ZLE, et al. J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):280-283. doi: 10.1136/jnnp-2022-330100. Epub 2022 Dec 23. J Neurol Neurosurg Psychiatry. 2023. PMID: 36564175
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Wieske L, Stalman EW, van Dam PJK, Kummer LY, Steenhuis M, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink G, Van der Kooi A, Raaphorst J, Löwenberg M, Takkenberg B, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl A, Broens B, Parra Sanchez A, van Els CACM, Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, Van der Pol WL, Goedee HS, Keijzer S, Keijser J, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Kuijpers TW, Rispens T, Eftimov F; T2B! immunity against SARS-CoV-2 study group. Wieske L, et al. Among authors: keijser j. Ann Rheum Dis. 2023 Jun;82(6):883-885. doi: 10.1136/ard-2022-223464. Epub 2023 Jan 31. Ann Rheum Dis. 2023. PMID: 36720583 No abstract available.
128 results